Curofy
Novel Drug May Offer Hope in Prader-Willi Syndrome, Obesity
The novel investigational drug beloranib (Zafgen) has produced significant weight loss and reduction of hyperphagia in a phase 3 randomized trial of patients with Prader-Willi syndrome.
See this content immediately after install